Research analysts at Piper Sandler started coverage on shares of Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) in a research note issued on Tuesday,Benzinga reports. The firm set a “neutral” rating and a $35.00 price target on the stock. Piper Sandler’s target price would indicate a potential upside of 12.61% from the stock’s current price.
KDP has been the subject of several other reports. Wells Fargo & Company reduced their price objective on Keurig Dr Pepper from $43.00 to $42.00 and set an “overweight” rating for the company in a research note on Friday, October 25th. Deutsche Bank Aktiengesellschaft raised Keurig Dr Pepper from a “hold” rating to a “buy” rating and increased their price target for the stock from $37.00 to $39.00 in a report on Thursday, December 12th. Barclays lowered their target price on shares of Keurig Dr Pepper from $41.00 to $39.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Jefferies Financial Group cut their price target on shares of Keurig Dr Pepper from $42.00 to $41.00 and set a “buy” rating for the company in a report on Friday, October 25th. Finally, TD Cowen lifted their price objective on Keurig Dr Pepper from $35.00 to $40.00 and gave the company a “hold” rating in a report on Thursday, September 26th. Six investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $38.36.
Get Our Latest Research Report on KDP
Keurig Dr Pepper Price Performance
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last issued its quarterly earnings data on Thursday, October 24th. The company reported $0.51 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.51. Keurig Dr Pepper had a net margin of 15.04% and a return on equity of 10.45%. The company had revenue of $3.89 billion for the quarter, compared to the consensus estimate of $3.92 billion. During the same period last year, the firm posted $0.48 EPS. Keurig Dr Pepper’s revenue for the quarter was up 2.3% on a year-over-year basis. As a group, equities analysts anticipate that Keurig Dr Pepper will post 1.92 EPS for the current year.
Insider Buying and Selling at Keurig Dr Pepper
In other Keurig Dr Pepper news, major shareholder Bevco B.V. Jab sold 69,000,000 shares of the stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $32.65, for a total transaction of $2,252,850,000.00. Following the sale, the insider now owns 214,443,879 shares in the company, valued at approximately $7,001,592,649.35. This represents a 24.34 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.00% of the stock is currently owned by insiders.
Institutional Trading of Keurig Dr Pepper
Institutional investors and hedge funds have recently made changes to their positions in the stock. CX Institutional grew its stake in shares of Keurig Dr Pepper by 3.6% in the third quarter. CX Institutional now owns 8,129 shares of the company’s stock valued at $305,000 after buying an additional 283 shares in the last quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors boosted its holdings in Keurig Dr Pepper by 3.6% in the 3rd quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors now owns 8,535 shares of the company’s stock worth $320,000 after acquiring an additional 300 shares during the period. Federated Hermes Inc. grew its position in Keurig Dr Pepper by 21.8% in the second quarter. Federated Hermes Inc. now owns 1,757 shares of the company’s stock valued at $59,000 after acquiring an additional 314 shares in the last quarter. TD Private Client Wealth LLC raised its stake in shares of Keurig Dr Pepper by 2.9% during the third quarter. TD Private Client Wealth LLC now owns 14,198 shares of the company’s stock valued at $532,000 after purchasing an additional 400 shares during the period. Finally, Crossmark Global Holdings Inc. lifted its position in shares of Keurig Dr Pepper by 1.1% during the third quarter. Crossmark Global Holdings Inc. now owns 37,775 shares of the company’s stock worth $1,415,000 after purchasing an additional 425 shares in the last quarter. 93.99% of the stock is currently owned by hedge funds and other institutional investors.
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Further Reading
- Five stocks we like better than Keurig Dr Pepper
- What Are Dividend Contenders? Investing in Dividend Contenders
- Will Berkshire Hathaway Continue to Dominate in 2025?
- What is MarketRank™? How to Use it
- 2 Agriculture Stocks To Benefit From a Trump Presidency in 2025
- What Investors Need to Know About Upcoming IPOs
- Uber’s Future: Analysts Forecast a 40% Stock Surge in 2025
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.